Background Primary percutaneous coronary intervention is the treatment of choice in ST-
segment elevation myocardial infarction and no-reflow phenomenon is still an unsolved …

Objective There is controversy whether nicorandil treatment has cardioprotective effects in
patients with acute myocardial infarction (AMI) following percutaneous coronary intervention …

Background: Nicorandil prior to reperfusion by primary percutaneous coronary intervention
(PCI) in patients with ST-segment elevated myocardial infarction (STEMI) has been …

Background Acute ST-segment elevation myocardial infarction (STEMI) remains a serious
life-threatening event. Despite coronary revascularization, patients might still suffer from …

Background This study aims to observe the effects of the intracoronary and peripheral
venous administration of nicorandil for the postoperative myocardial microcirculation and …

Introduction: Nicorandil may exert cardioprotective effects in ischemic heart disease.
However, its efficacy in combination with early reperfusion is uncertain. The authors …

Background The potential myocardial protective effect of nicorandil (NICD) in patients
undergoing percutaneous coronary intervention has been established. However, its efficacy …

Nicorandil is a dual mechanism anti-anginal agent that acts as a nitric oxide (NO) donor and
a potassium (K+) channel opener. Recent studies have evaluated the effect of nicorandil on …

Aims To study the effect of nicorandil on prognosis of patients with acute myocardial
infarction (AMI) undergoing percutaneous coronary intervention (PCI). Methods We retrieved …

Aim We aim to explore the factors influencing myocardial perfusion in patients with acute ST-
segment elevation myocardial infarction (STEMI) after primary percutaneous coronary …